Multimodal Prediction of Early Treatment Failure after BCMA CAR-T Incorporating PET Derived Tumor Burden and Lymphocyte Subsets

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Ciara Louise Freeman, Robert C Norberg, Dietrich Werner Idiáquez, K. Ruwani M. Fernando, Yoganand Balagurunathan, Nicholas B. Figura, Daniel Deavila, Gabriel De Avila, Praneeth Reddy Sudalagunta, Ariosto Silva, Omar Alexis Castaneda Puglianini, Hien Duong Liu
+11 more Brandon Jamaal Blue, Rachid C Baz, Melissa Alsina, Taiga Nishihori, Rolf Petter Tonseth, Rachel Howard, Ariel Felipe Grajales-Cruz, Frederick Lundry Locke, Kenneth H. Shain, Doris K. Hansen, Issam M. El Naqa
DOI: 10.1016/j.jtct.2025.12.059
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S36–S37
Publication date
1 February 2026
Language
EN